home / stock / thcx / thcx news


THCX News and Press, Spinnaker ETF Series The Cannabis From 04/06/23

Stock Information

Company Name: Spinnaker ETF Series The Cannabis
Stock Symbol: THCX
Market: NYSE

Menu

THCX THCX Quote THCX Short THCX News THCX Articles THCX Message Board
Get THCX Alerts

News, Short Squeeze, Breakout and More Instantly...

THCX - InterCure: How Bright Is The Company's Future In 2023

2023-04-06 10:24:11 ET Summary Despite continued market challenges for the cannabis industry, InterCure's revenue continues to grow year-on-year and, more importantly, quarter-on-quarter to NIS 105.6 million in Q4 2022. InterCure's total comprehensive profit was NIS 43.7 million i...

THCX - Pragmatic Cannabis Investing

2023-03-15 17:00:00 ET Summary Pelorus Equity Group's Rob Sechrist shares valuable advice for retail investors in the cannabis space. Scale is not the ultimate driver of cannabis companies. Outliers in California cannabis. Cannabis investing in a deflationary environment. ...

THCX - A Close Look At 13 Cannabis ETFs

Summary Cannabis ETFs began to hit the market in 2017. As cannabis stocks have declined, they have lost their popularity. I review the small universe and find none that seem worthy of investment. Investors that want to invest in cannabis can do better picking stocks in my view. ...

THCX - Looking For The Cheapest Cannabis Stocks (Transcript)

Summary Cannabis stocks are really cheap, but Alan Brochstein is worried about 3 things. Thoughts on Cresco/Columbia Care deal. Sector debt and optimal cannabis investing metrics. Canadian and US operators. Concerns around MSOS; limitations of ETFs. Why Alan's 19% in cash. ...

THCX - What Cannabis Stocks Should Be In Your Portfolio?

Summary Nick Gastevich, aka CannaVestments, one of our favorite commenters on Seeking Alpha, returns for a super actionable take on cannabis stocks. Focus on companies that control their own destinies as much as possible. Which balance sheets are in trouble and who's generating real...

THCX - InterCure: Why The Company Is Grossly Undervalued By Wall Street

Summary InterCure earned CAD$39 million in Q3 2022, up 61.2% from the previous year. Moreover, at the end of Q4 2022, the total number of licensed patients using cannabis for medical purposes in Israel was 123,212, up 13,860 from the previous year. Currently, the cannabis industry c...

THCX - Markets Don't Move In Straight Lines

Summary The most consistent progress in cannabis is coming from states continuing to roll out legalization programs. For cannabis companies wanting to make a profit in these legal markets, there is both opportunity and a need to navigate growing pains. A reminder from Tim Seymo...

THCX - Cannabis Is A Commodity

Summary As the industry develops, lots of talk recently around cannabis consumption lounges and cannabis tourism in Colorado, Nevada and beyond. What it's like to grow the cannabis economy with Chris Chiari, CEO/Founder of The 420 Hotels. Cannabis is a commodity - what that means fo...

THCX - What's The Deal With New York Cannabis?

Summary Legal cannabis has officially hit New York. Two long-time NY advocates, Allan Gandelman and Kaelan Castetter, provide context for this moment. When does supply meet demand? Why the two-tier system works and will likely be a federal model. Inflated value of NY licenses ha...

THCX - Anxiety-Free Cannabis Investing

Summary What history tells us about the future of cannabis. Cannabis is advancing and nothing can stop it. For the future of cannabis, look beyond the past. Anxiety and worry don't have to be part of cannabis investing. Cannabis investors have been ravaged and buffeted...

Previous 10 Next 10